Recommendation ID
CG131/5
Question
Patient-reported outcome measures in colorectal cancer:- Colorectal cancer-specific patient-reported outcome measures (PROMs) should be developed for use in disease management and to inform outcome measures in future clinical trials.
Any explanatory notes
(if applicable)
Why this is important:- Quality of life and PROMs are now frequently being used as secondary endpoints in clinical trials of cancer management. However, some investigators continue to use non-disease-specific generic methodology for this purpose. The treatment of colorectal cancer leads to very specific side effects relating to bowel function and activities of daily living. The Guideline Development Group therefore believes that colorectal cancer-specific patient-reported outcome measures should be developed to standardise the interpretation of quality-of-life reporting as a secondary endpoint in future clinical trials in colorectal cancer.

Source guidance details

Comes from guidance
Colorectal cancer: diagnosis and management
Number
CG131
Date issued
November 2011

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 06/01/2015